Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells. - Wikidata - awgldk - TriplyDB

Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells.

Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells.

http://www.wikidata.org/entity/Q40302578

about

ERdj5 sensitizes neuroblastoma cells to endoplasmic reticulum stress-induced apoptosis Seed Oil of Brucea javanica Induces Apoptotic Death of Acute Myeloid Leukemia Cells via Both the Death Receptors and the Mitochondrial-Related Pathways Cancer wars: natural products strike back Altering chemosensitivity by modulating translation elongation Deficiency of suppressor enhancer Lin12 1 like (SEL1L) in mice leads to systemic endoplasmic reticulum stress and embryonic lethality Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation.Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors.Omacetaxine mepesuccinate: a new treatment option for patients with chronic myelogenous leukemia.Investigation into omacetaxine solution stability for in vitro study.Identification of genetic variants or genes that are associated with Homoharringtonine (HHT) response through a genome-wide association study in human lymphoblastoid cell lines (LCLs)A comparative proteomic study of Homoharringtonine-induced apoptosis in leukemia K562 cells.Proteostasis regulation at the endoplasmic reticulum: a new perturbation site for targeted cancer therapy.Integrated stress response modulates cellular redox state via induction of cystathionine γ-lyase: cross-talk between integrated stress response and thiol metabolism.Emerging therapeutics targeting mRNA translation High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor Type I interferons mediate pancreatic toxicities of PERK inhibition.ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo.Differential control of the CCAAT/enhancer-binding protein beta (C/EBPbeta) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol.Absence of iron-regulatory protein Hfe results in hyperproliferation of retinal pigment epithelium: role of cystine/glutamate exchanger Homoharringtonine for the treatment of chronic myelogenous leukemia.Inhibitory effect of magnetic Fe3O4 nanoparticles coloaded with homoharringtonine on human leukemia cells in vivo and in vitro.Homoharringtonine and omacetaxine for myeloid hematological malignancies.Advances in treatment of chronic myelogenous leukemia--new treatment options with tyrosine kinase inhibitors.The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia.New drugs for chronic myelogenous leukemia.Targeting translation dependence in cancer Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development.Omacetaxine mepesuccinate (synribo) - newly launched in chronic myeloid leukemia.Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia.Omacetaxine mepesuccinate in chronic myeloid leukemia.ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner.A safety evaluation of omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia.Homoharringtonine as a backbone drug for the treatment of newly diagnosed pediatric acute myeloid leukemia: a report from a single institution in China.Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells.Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers.A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China Loss of the Atp2c1 secretory pathway Ca(2+)-ATPase (SPCA1) in mice causes Golgi stress, apoptosis, and midgestational death in homozygous embryos and squamous cell tumors in adult heterozygotes.Inhibition of myeloid cell leukemia-1 by tolfenamic acid induces apoptosis in mucoepidermoid carcinoma.

P2860

Q24313289-D4A976BB-7227-48D3-A411-982E37E22D15 Q24594585-02E79B0D-4F1C-4A40-A51E-BBB919B00C40 Q26850074-5FD68A80-ACD6-49DB-AE4E-3145D2036E1F Q27349402-04DDFB75-BD58-49CE-9675-5E85B9BD5743 Q28587457-1AD1A0B6-FC00-4F31-AE3A-952A9B5F28BC Q33402841-7CC4B565-E4BA-44DD-A0B3-FC71D78A2CF7 Q33406299-01DDCCF5-C133-4C97-AF8C-B4F63439BEFC Q33886011-0B6A006C-9D36-40A2-B9DA-CF433E46E841 Q33989052-17393540-C7A4-447D-B49C-085F519BBB37 Q34937030-979107C9-ED9C-41CB-9E5E-E64ADF1DD86F Q35351625-AAAA0B3F-BCDB-4E79-B463-723BBB98C677 Q35469778-FB3126D2-FA0D-4497-A58E-4B53C84B8540 Q35801960-00C913AE-21F6-4672-B735-96DF84ECC137 Q35853794-3CF04F55-96BA-468D-89FD-F8128CD2565C Q36231927-B654357F-3BFC-400F-9E7B-295E423983EB Q36347246-0F52E200-EF50-47E9-882E-D206371CB297 Q36394344-66029ECD-1DE3-4CDC-9DB5-EC106B4A39A3 Q36640055-11E0A38D-C7E7-4A0A-9AD8-E168909FCFD3 Q36825517-C6B3070B-B2E5-4015-BA4A-8F45A5553146 Q36914970-61D56239-0E5C-4900-9329-5BB31CA8671F Q37035485-EA7D7425-0C75-48B4-9845-F312010C8EDE Q37123425-61C5BB67-5BE4-43BA-B089-E7D71C08AC55 Q37248812-D9052452-404A-4EE6-8D9A-873EE470738E Q37446279-6F4719A5-A75F-4242-BD7F-E88D4AF82E37 Q37657488-1CAEE926-D68F-497B-8FC9-16D58844127B Q37706488-EF574B5F-FD7F-4344-92F2-252A8F697155 Q37843769-10347E66-FC04-4FCD-BEDE-DEA3C29ADF6C Q37850227-1776D909-4978-4619-AAD7-2A7540F9CBF4 Q38088759-38F6DD8F-EE11-463F-ACAC-E6EC0A2479B5 Q38123196-06E27505-4ED7-4F21-AC40-2B1775866BE6 Q38187115-B0009326-E419-4CCD-B880-7D784A27CCE3 Q38258641-A9F5F11D-013D-4872-B60F-BD784F2ECA01 Q38758632-992262F8-67C0-49AC-A4F3-37095E4275AA Q38846325-574A1378-6C8B-4E86-810B-00761D31571B Q39758498-80CA8DD7-A5CE-453C-A472-796EA6EBC5A5 Q39804531-2A65CE01-35A7-4F1C-AE62-C8B3FD1747FC Q41701637-069E214B-26BD-4CFA-8566-9D2E51BDDE22 Q41783006-87807052-8199-4F09-AC1C-A210D154DA76 Q42624776-37D65080-7DAD-490E-A73F-E5AD2A461AB0 Q42816325-92BD9CBA-5F20-4E5A-BD00-BCE9B5ADAE20

P2860

Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells.

http://www.wikidata.org/entity/Q40302578

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Semisynthetic homoharringtonin ...... ion in myeloid leukemia cells.

@en

type

label

Semisynthetic homoharringtonin ...... ion in myeloid leukemia cells.

@en

prefLabel

Semisynthetic homoharringtonin ...... ion in myeloid leukemia cells.

@en

P1433

Q40302578-43B17F00-7681-4F42-8E1B-098DD3A5CBC6

P1476

Q40302578-9426A274-9BB4-459E-B868-27C79B225000

P2093

Q40302578-2BB38B8F-8528-48B3-9E4C-EA1CC2C68436

Q40302578-366C3ABD-233E-4B0D-9739-4C0AC1CB2161

Q40302578-5233DAC0-7924-40A8-98B0-7A4B39E74C3F

Q40302578-537D8035-20AF-4B9C-9062-8636D0E0EFE6

Q40302578-615C66F4-051D-4709-BC10-2E334B46B9BA

Q40302578-6D844944-6C93-4487-93B5-D69DED1FF1FF

Q40302578-A16F3ED7-631F-4435-8E1A-EF7B420DAE20

Q40302578-A8E4CCD3-D185-4680-A250-90557E778E3E

P304

Q40302578-D4176745-BABF-419E-8302-C601807418DF

P31

Q40302578-52D1B3FA-0781-4BFC-89B5-81F41F754191

P356

Q40302578-C748CEFA-A593-4C45-9DD1-3F5B6B997816

P433

Q40302578-A7658F38-9CC1-4185-92BB-6B0CBC4FB6F6

P478

Q40302578-97B644D1-8890-4164-B452-99F775D25249

P577

Q40302578-98A15EAE-69C4-4E75-A89B-B6421A5CEF45

P698

Q40302578-90621EA0-01F5-45A3-A07B-9ED7CE2CECDE

P921

Q40302578-8E326570-7D63-4EB9-97EA-A5D7F166F84C

P356

1535-7163.MCT-05-0164

P1433

Molecular Cancer Therapeutics

P1476

Semisynthetic homoharringtonin ...... ion in myeloid leukemia cells.

@en

P2093

Anne-Marie Faussat

http://www.w3.org/2001/XMLSchema#string

Christophe Marzac

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Marie

http://www.w3.org/2001/XMLSchema#string

Ollivier Legrand

http://www.w3.org/2001/XMLSchema#string

Patricia Majdak

http://www.w3.org/2001/XMLSchema#string

Ruoping Tang

http://www.w3.org/2001/XMLSchema#string

Sabine Dubrulle

http://www.w3.org/2001/XMLSchema#string

Zora Marjanovic

http://www.w3.org/2001/XMLSchema#string

P304

723-731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-05-0164

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16546987

http://www.w3.org/2001/XMLSchema#string

P921